Crossmark

Mechanistic evaluation of hyperoside against non-small cell lung cancer: a combined approach of network pharmacology and in vitro experimental validation

Crossref DOI link: https://doi.org/10.1007/s12672-025-03622-9

Published Online: 2025-09-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xu, Shuang

Zou, Yaping

Luo, Guangwen

Tang, Liu

Zhan, Haichao

Huang, Lili

Zhang, Zhaowei
Funding

Funding for this research was provided by:

Jinhua Traditional Chinese Medicine Science and Technology Plan Project (2025LC04, 2025LC04, 2025LC04, 2025LC04, 2025LC04)

Initial Scientific Research Foundation for Affiliated Jinhua Hospital, Zhejiang University School of Medicine (JY2019-2-01, JY2019-2-01, JY2019-2-01, JY2019-2-01)
License Information

Text and Data Mining valid from 2025-09-29

Version of Record valid from 2025-09-29
More Information

Article History

Received: 21 April 2025

Accepted: 8 September 2025

First Online: 29 September 2025

Declarations

:

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below